Business Description
BRAIN Biotech AG
ISIN : DE0005203947
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.42 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -3.08 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.46 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.3 | |||||
3-Year EBITDA Growth Rate | 30.1 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | 8.4 | |||||
3-Year Book Growth Rate | -1.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 25.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.57 | |||||
9-Day RSI | 56.32 | |||||
14-Day RSI | 51.28 | |||||
6-1 Month Momentum % | -23.66 | |||||
12-1 Month Momentum % | -43.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.01 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 143.46 | |||||
Days Sales Outstanding | 55.81 | |||||
Days Payable | 72.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.69 | |||||
Operating Margin % | -9.22 | |||||
Net Margin % | -14.53 | |||||
FCF Margin % | -3.34 | |||||
ROE % | -37.31 | |||||
ROA % | -11.34 | |||||
ROIC % | -8.98 | |||||
ROC (Joel Greenblatt) % | -27.04 | |||||
ROCE % | -11.26 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.14 | |||||
PB Ratio | 3.44 | |||||
Price-to-Tangible-Book | 16.65 | |||||
EV-to-EBIT | -8.54 | |||||
EV-to-EBITDA | -30.36 | |||||
EV-to-Revenue | 1.03 | |||||
EV-to-FCF | -31.01 | |||||
Earnings Yield (Greenblatt) % | -11.7 | |||||
FCF Yield % | -7.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BRAIN Biotech AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 55.368 | ||
EPS (TTM) (€) | -0.37 | ||
Beta | 1.52 | ||
Volatility % | 45.43 | ||
14-Day RSI | 51.28 | ||
14-Day ATR (€) | 0.067956 | ||
20-Day SMA (€) | 2.73 | ||
12-1 Month Momentum % | -43.31 | ||
52-Week Range (€) | 2.66 - 4.79 | ||
Shares Outstanding (Mil) | 21.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BRAIN Biotech AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BRAIN Biotech AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
BRAIN Biotech AG Frequently Asked Questions
What is BRAIN Biotech AG(HAM:BNN)'s stock price today?
When is next earnings date of BRAIN Biotech AG(HAM:BNN)?
Does BRAIN Biotech AG(HAM:BNN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |